We’re here to help you achieve your strategic objectives.
Q2 2025 Healthcare M&A Spotlight
August 14, 2025 | Insights
Healthcare M&A activity was flat through Q2 2025, roughly in line with 2024. However, we see positive signs for a gradual increase during the second half and into 2026. Despite ongoing policy uncertainty, sponsors are becoming more focused on the right process timing for the company and fund, rather than trying to time the market, and valuation multiples have stabilized around pre-pandemic averages. This report explores broad M&A market trends and insights into Bailey & Company’s four main coverage areas: healthcare services, healthcare IT & tech-enabled services, payer services, and pharma services & life sciences.
Download the report by filling out the form. Please contact us to request more information.
Download Now
CONTACT INFORMATION
Rebecca Springer
Director, Market Development
Collin Anderson
Senior Analyst, Market Development
ABOUT BAILEY & COMPANY
Bailey is a Nashville-based merchant banking platform focused on growth and late-stage healthcare and technology companies. Through the firm’s M&A advisory and strategic fund businesses, Bailey supports strong management teams that have built scalable platforms by providing strategic insights, world class advice, and access to one of the most diverse networks of industry experts. Since our founding, our senior bankers have closed over 200 transactions representing more than $17B in value. For more information see: www.bnco.com.
